131
Participants
Start Date
June 13, 2024
Primary Completion Date
November 11, 2024
Study Completion Date
November 11, 2024
Personally-Tailored Opioid-overdose and Medication for opioid use disorder (MOUD) Education (TOME)
The TOME intervention is a modified version of the personally-tailored opioid overdose prevention education and naloxone distribution (PTOEND) intervention (Winhusen et al. Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids. Drug Alcohol Depend. Nov 1 2020;216:108265). Modifications include updating the knowledge assessment/education to reflect changes in the drug supply (i.e., the current high prevalence of fentanyl and increasing prevalence of xylazine) and the addition of items specific to pregnancy. Like PTOEND, TOME is a computer-guided intervention which utilizes REDCap to complete assessments and automatically generate personally-tailored feedback reports.
Control
Participants randomized to the control condition will be offered three SAMHSA handouts.
Pregnancy Recovery Center at Magee-Womens Hospital of UPMC, Pittsburgh
Marshall Health MARC Program, Huntington
Medical University of South Carolina, Charleston
Gateway Community Services, Jacksonville
Vanderbilt University Medical Center, Nashville
University of Utah SUPeRAD Clinic, Salt Lake City
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
National Institute on Drug Abuse (NIDA)
NIH
T. John Winhusen, PhD
OTHER